Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists

被引：5

作者：

Kiyoi, Takao ^{[1
]}

Adam, Julia M. ^{[1
]}

Clark, John K. ^{[1
]}

Davies, Keneth ^{[1
]}

Easson, Anna-Marie ^{[1
]}

Edwards, Darren ^{[1
]}

Feilden, Helen ^{[1
]}

Fields, Ruth ^{[1
]}

Francis, Stuart ^{[1
]}

Jeremiah, Fiona ^{[1
]}

McArthur, Duncan ^{[1
]}

Morrison, Angus J. ^{[1
]}

Prosser, Alan ^{[1
]}

Ratcliffe, Paul D. ^{[1
]}

Schulz, Jurgen ^{[1
]}

Wishart, Grant ^{[1
]}

Baker, James ^{[2
]}

Campbell, Robert ^{[2
]}

Cottney, Jean E. ^{[2
]}

Deehan, Maureen ^{[2
]}

Epemolu, Ola ^{[2
]}

Evans, Louise ^{[2
]}

机构：

[1] Merck Res Labs, Dept Chem, MSD, Newhouse ML1 5SH, Lanark, Scotland

[2] Merck Res Labs, Dept Pharmacol, MSD, Newhouse ML1 5SH, Lanark, Scotland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 06期

关键词：

Cannabinoid; CB1 receptor agonist; Oral bioavailability; NITRILE SULFIDES; DRUG DISCOVERY; PAIN; INDOLE-3-CARBOXAMIDES; GENERATION; DESIGN; MODELS;

D O I：

10.1016/j.bmcl.2011.01.082

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Novel 3-(1H-indol-3-yl)-1,2,4-oxadiazoles and -thiadiazoles were synthesized and found to be potent CB1 cannabinoid receptor agonists. The oral bioavailability of these compounds could be dramatically improved by optimization studies of the side chains attached to the indole and oxadiazole cores, leading to identification of a CB1 receptor agonist with good oral activity in a range of preclinical models of antinociception and antihyperalgesia. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：1748 / 1753

页数：6

共 50 条

[41] Signal transduction of the CB1 cannabinoid receptor
Turu, Gabor
Hunyady, Laszlo
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2010, 44 (02) : 75 - 85
[42] Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB1 receptor
Ryalls, Beth
Patel, Monica
Sparkes, Eric
Banister, Samuel D.
Finlay, David B.
Glass, Michelle
BIOCHEMICAL PHARMACOLOGY, 2024, 222
[43] Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
Franks, Lirit N.
Ford, Benjamin M.
Prather, Paul L.
FRONTIERS IN PHARMACOLOGY, 2016, 7
[44] Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective Agonists
Ashton, John C.
Wright, Jason L.
McPartland, John M.
Tyndall, Joel D. A.
CURRENT MEDICINAL CHEMISTRY, 2008, 15 (14) : 1428 - 1443
[45] Discovery of Potent, Orally Bioavailable Phthalazinone Bradykinin B1 Receptor Antagonists
Biswas, Kaustav
Peterkin, Tanya A. N.
Bryan, Marian C.
Arik, Leyla
Lehto, Sonya G.
Sun, Hong
Hsieh, Feng-Yin
Xu, Cen
Fremeau, Robert T.
Allen, Jennifer R.
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (20) : 7232 - 7246
[46] Aminopyrazine CB1 receptor inverse agonists
Wustrow, David J.
Maynard, George D.
Yuan, Jun
Zhao, He
Mao, Jianmin
Guo, Qin
Kershaw, Mark
Hammer, Jack
Brodbeck, Robbin M.
Near, Kristen E.
Zhou, Dan
Beers, David S.
Chenard, Bertrand L.
Krause, James E.
Hutchison, Alan J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (11) : 3376 - 3381
[47] The discovery of novel indole-2-carboxamides as cannabinoid CB1 receptor antagonists
Cowley, Phillip M.
Baker, James
Barn, David R.
Buchanan, Kirsteen I.
Carlyle, Ian
Clark, John K.
Clarkson, Thomas R.
Deehan, Maureen
Edwards, Darren
Goodwin, Richard R.
Jaap, David
Kiyoi, Yasuko
Mort, Chris
Palin, Ronald
Prosser, Alan
Walker, Glenn
Ward, Nick
Wishart, Grant
Young, Trevor
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (01) : 497 - 501
[48] Discovery of Selenium-Containing Derivatives as Potent and Orally Bioavailable GLP-1R Agonists
Chen, Xuetao
Xu, Shicheng
Yang, Shuang
Yu, Zezhou
Chen, Yali
Wu, Huidan
Bao, Qichao
You, Qidong
Guo, Xiaoke
Jiang, Zhengyu
JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (03) : 3386 - 3408
[49] The influence of selective agonists at cannabinoid CB1 receptor and CB2 receptor on sensitization to methamphetamine behavioural effects in mice
Landa, L
Slais, K
Sulcova, A
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S37 - S37
[50] Cannabinoid CB1 receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo
Acquas, E
Pisanu, A
Marrocu, P
Di Chiara, G
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 401 (02) : 179 - 185

← 1 2 3 4 5 →